Since NPS-2143 treatment hindered growth of breast cancer cells, we further assessed the underlying molecular mechanism responsible for this growth suppression by measuring caspase-3/7 activities as a way to predict cellular apoptosis. This evidence concerns the gene CASP3 and breast cancer.